1. News
  2. Barcelona distinguishes Eduard Batlle's metastasis research

Barcelona distinguishes Eduard Batlle's metastasis research

ICREA research professor Eduard Batlle
ICREA research professor Eduard Batlle
1 Feb 2019

Awards for outstanding creation, research and production developed in Barcelona

The Barcelona City Council acknowledges the impact of his studies in cancer and metastasis

The Barcelona City Council has announced the names of the winners of the 2018 Premi Ciutat de Barcelona, the highest accolade bestowed by the city on its citizens. Eduard Batlle, ICREA researcher, group leader and coordinator of the Cancer Science Programme at IRB Barcelona and a CIBERONC member, has been given this prize in the  “Life Sciences” category.

Eduard Batlle receives this institutional recognition for his recent article published in the journal Nature, which describes the discovery of the new mechanism that allows cancer cells to evade detection by the immune system and to form metastases. This finding reveals new approaches through which to increase the success of immunotherapy treatments in advanced stages of certain kinds of cancer.

The award ceremony for the 2018 Premis Ciutat de Barcelona will be held on Thursday 14 February at 18:00, in the “Saló de Cent” of the Barcelona City Council, and will be chaired by the mayor of Barcelona, Ada Colau, and the Commissioner for Culture of the Council, Joan Subirats, and led by the actress Àgata Roca.

This is the third time that an IRB Barcelona researcher has been given this prize: the first scientist to receive it was Ernest Giralt (Head of the Peptides and Proteins Laboratory), in 2014, followed  by Salvador Aznar (Head of the Stem Cells and Cancer Laboratory), in  2016.

The “Premis Ciutat de Barcelona” have been given yearly since 1949 by the Barcelona City Council in  recognition of excellence in a variety of fields, including research and production, by creative individuals and groups working in these areas or by organisations in Barcelona that devoted to them or promote them.

 

More information about the Premis Ciutat de Barcelona.

About IRB Barcelona

Created in 2005 by the Generalitat de Catalunya (Government of Catalonia) and University of Barcelona, IRB Barcelona is a Severo Ochoa Centre of Excellence, a seal that was awarded in 2011. The institute is devoted to conducting research of excellence in biomedicine and to transferring results to clinical practice, thus improving people’s quality of life, while simultaneously promoting the training of outstanding researchers, technology transfer, and public communication of science. Its 27 laboratories and seven core facilities address basic questions in biology and are orientated to diseases such as cancer, metastasis, Alzheimer’s, diabetes, and rare conditions. IRB Barcelona is an international centre that hosts 400 employees and more than 30 nationalities. It is located in the Barcelona Science Park. IRB Barcelona forms part of the Barcelona Institute of Science and Technology (BIST) and the “Xarxa de Centres de Recerca de Catalunya” (CERCA).

Ciutat de Barcelona
metastasis
colorectal cancer
inmunotherapy

Related content

News

<p>The discovered type of diffuse hypermutation is called "mutation fog". (Dave Hoefler, Unsplash)</p>

Mutations in cancer genomes: foggy with a chance of thunderstorms

The mechanism unveiled triggers a mutation fog, causing hundreds of mutations in each tumor, which spread through the genome of lung, head-and-neck and breast cancers.

Researchers from the Genome Data Science Lab have identified the antiviral APOBEC3A enzyme as the major cause of this new type of hypermutation.

Published in Nature Genetics, the study shows how the mutation fog process generates many oncogenic “cancer driver” mutations, thus accelerating tumour development.

<p>Clara Morral, Postdoctoral Fellow at IRB Barcelona</p>

An interview with Clara Morral, Postdoctoral Fellow at IRB Barcelona

Clara Morral is the first author of an article recently published in the scientific journal Cell Stem Cell.

The study identifies that protein synthesis is a key property for the regenerative potential of colon cancer cells.

<p>Roger Gomis, head of the Growth Control and Metastasis Lab at IRB Barcelona</p>

World Cancer Day

To mark World Cancer Day, the programme El Matí de Barcelona Betevé broadcasted by Radio Barcelona has interviewed Roger Gomis, ICREA Researcher and head of the Growth Control and Metastasis Lab at IRB Barcelona. During the interview, he talked about metastasis, the process by which a tumour spreads to the rest of the body, allowing cancer cells to adapt to new environments “What we are focusing on in our lab is precisely how this cell adaptation and plasticity comes about,” says Gomis.